Modeling red blood cell survival data

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 38, Issue 6, 2011, Pages 787-801

  Korell, Julia ^a   Vos, Frederiek E ^a   Coulter, Carolyn V ^a   Schollum, John B ^b   Walker, Robert J ^b   Duffull, Stephen B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Chronic kidney disease; Hemodialysis; Lifespan; MONOLIX; Population approach; Radioactive chromium; Random destruction; Red blood cells; Senescence; Two stage approach

Indexed keywords

CHROMIUM;

ADULT; ARTICLE; CELL LOSS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE LIFESPAN; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; POPULATION MODEL; PRIORITY JOURNAL; SENESCENCE; STATISTICAL MODEL;

ANEMIA; CASE-CONTROL STUDIES; CELL SURVIVAL; CHROMIUM RADIOISOTOPES; ERYTHROCYTES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RENAL DIALYSIS;

EID: 84855687609     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-011-9220-6     Document Type: Article

References (41)

1. Hsu C, Mcculloch C, Curhan G (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13(2):504-510 (Pubitemid 34106294)
2. Mcclellan W, Aronoff S, Bolton W, Hood S, Lorber D, Tang K, Tse T, Wasserman B, Leiserowitz M (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20(9):1501-1510. doi:10.1185/ 030079904X2763 (Pubitemid 39361354)
3. Eschbach J, Funk D, Adamson J, Kuhn I, Scribner B, Finch C (1967) Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276(12):653-658
4. Loge J, Lange R, Moore C (1958) Characterization of the anemia associated with chronic renal insufficiency. Am J Med 24:4-18
5. Joske R, Mcalister J, Prankerd A (1956) Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sci 15(4):511-522
6. Ly J, Marticorena R, Donnelly S (2004) Red blood cell survival in chronic renal failure. Am J Kidney Dis 44(4):715-719 (Pubitemid 39237616)
7. Desforge J, Dawson J (1958) The anemia of renal failure. Arch Intern Med 101:326-332
8. Schwartz A, Keich B, Terzian L, Prior J, Kim K, Pequinot E, Kahn S (1990) One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis. ASAIO J 36(3):M691-M696 (Pubitemid 20367169)
9. Polenakovic M, Sikole A (1996) Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol 7(8):1178-1182 (Pubitemid 27468270)
10. Cotes P, Pippard M, Reid C, Winearls C, Oliver D, Royston J (1989) Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med 70(262):113-137 (Pubitemid 19115952)
11. Pavlovic-Kentera V, Clemons G, Djukanovic L, Biljanovic-Paunovic L (1987) Erythropoietin and anemia in chronic renal failure. Exp Hematol 15(7):785-789 (Pubitemid 17151452)
12. Ebaugh F, Emerson C, Roos J (1953) The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination of red cell survival in vivo. J Clin Invest 29(12):1260-1276
13. International Committee for Standardization in Haematology (1980) Recommended method for radioisotope red-cell survival studies. Br J Haematol 45(4):659-666
14. Audi G, Bersillon O, Blachot J, Wapstra A (1997) The NUBASE evaluation of nuclear and decay properties. Nucl Phys A 624(1):1-124 (Pubitemid 127169618)
15. Cline M, Berlin N (1963) The red cell chromium elution rate in patients with some hematologic diseases. Blood 21(1):63-69
16. Necheles T, Weinstein I, Leroy G (1953) Radioactive sodium chromate for the study of survival of red blood cells: I. The effect of radioactive sodium chromate on red cells. J Lab Clin Med 42(3): 358-367
17. Willekens F, Roerdinkholder-Stoelwinder B, Groenen-Doepp Y, Bos H, Bosman G, Van Den Bos A, Verkleij A, Werre J (2003) Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101(2):747-751 (Pubitemid 36077602)
18. Saha G (2010) Fundamentals of nuclear pharmacy, 6th edn. Springer, New York
19. Woo S, Krzyzanski W, Jusko W (2007) Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J Pharmacokinet Pharmacodyn 34(6): 849-868 (Pubitemid 350165278)
20. Bonomi F, Stefanelli M (1980) REDCE: A computer program for the analysis of red cell survival data. Comput Programs Biomed 12(2-3):172-182 (Pubitemid 11110829)
21. Freise K, Widness J, Schmidt R, Veng-Pedersen P (2008) Modeling time variant distributions of cellular lifespans: Increases in circulating reticulocyte lifespans following double phlebotomies in sheep. J Pharmacokinet Pharmacodyn 35(3):285-323
22. Krzyzanski W, Ramakrishnan R, Jusko W (1999) Basic pharmacodynamic models for agents that alter production of natural cells. J Pharmacokinet Biopharm 27(5):467-489 (Pubitemid 30497279)
23. Berlin N, Waldmann T, Weissmann S (1959) Life span of red blood cell. Physiol Rev 39(3):577-616
24. Kalicki R, Lledo R, Karlsson M (2009) Modeling of red blood cell life-span in a hematologically normal population. PAGE 18 (2009) Abstr 1677 [http:www.page-meeting.org/?abstract=1677], St. Petersburg, Russia
25. Korell J, Coulter C, Duffull S (2011) A statistical model for red blood cell survival. J Theor Biol 268(1):39-49. doi:10.1016/j.jtbi.2010.10.010
26. Korell J, Coulter C, Duffull S (2011) Evaluation of red blood cell labelling methods based on a statistical model for red blood cell survival. J Theor Biol (in press). doi:10.1016/j.jtbi.2011.09.016
27. Vos F, Schollum J, Coulter C, Doyle T, Duffull S, Walker R (2011) Red blood cell survival in longterm dialysis patients. Am J Kidney Dis. (in press). doi:10.1053/j.ajkd.2011.03.031
28. Sheiner L, Beal S (1985) Pharmacokinetic parameter estimates from several least squares procedures: Superiority of extended least squares. J Pharmacokinet Pharmacodyn 13(2):185-201. doi:10.1007/ bf01059398 (Pubitemid 15012931)
29. Ette E, Williams P (2004) Population pharmacokinetics II: Estimation methods. Annals Pharmacother 38(11):1907
30. Lavielle M, Group M (2004) SAEM in MATLAB: An alternative to linearization. PAGE 13 (2004) Abstr 544 [http:www.page-meeting.org/?abstract= 544]
31. Lavielle M, Mentré F (2007) Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. J Pharmacokinet Pharmacodyn 34(2):229-249. doi:10.1007/s 10928-006-9043-z (Pubitemid 46536259)
32. Lavielle M (2005) MONOLIX 1.1. User manual laboratoire de mathematiques. Universite Paris-Sud, Orsay
33. Eadie G, Brown I (1953) Analytic review: Red blood cell survival studies. Blood 8:1110-1136
34. Shaw A (1967) Haemolysis in chronic renal failure. Br Med J 2:213-216
35. Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Loscalzo J (2008) Harrison's principles of internal medicine, 17th edn. McGraw-Hill Companies, New York
36. Znojil V (1983) An ignored error in the mathematical formulation of erythrocyte survival curves. J Theor Biol 102(4):625-628. doi:10.1016/0022- 5193(83)90395-8
37. 51Cr red cell survival studies. Br J Haematol 26(2):179-184
38. Szymanski I, Valeri C (1970) Factors influencing chromium elution from labelled red cells in vivo and the effect of elution on red-cell survival measurements. Br J Haematol 19(3):397-409
39. Taylor H, Whitley P, Heaton A (2006) A historical perspective on platelet radiolabeling techniques. Transfus (Paris) 46(s3):53S-58S (Pubitemid 44656909)
40. International Committee for Standardization in Haematology (1977) Recommended methods for radioisotope platelet survival studies: By the panel on Diagnostic Application of Radioisotopes in Hematology. Blood 50(6):1137-1144
41. Eyre H, Rosen P, Perry S (1970) Relative labeling of leukocytes, erythrocytes and platelets in human blood by 51Chromium. Blood 36(2):250-253